Eating Disorders Trial, Recruiting NCT07143981 Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT07143981
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with anorexia nervosa (restricting type) that is moderate or severe, meaning your BMI is below 17
  • You are willing and able to swallow capsules as part of the treatment without vomiting them up
  • You can read and understand conversational English

Who may not be able to join:

  • You are currently in a medically or mentally unstable condition that requires a hospital stay
  • You have the binge/purge type of anorexia nervosa (rather than the restricting type)
  • You have taken antibiotics or probiotic supplements in the month before starting treatment
  • You regularly take steroid tablets by mouth, or use strong steroid creams or ointments on large areas of your skin
  • You have a long-term condition that weakens your immune system, or a long-term illness that affects your gut or your body's ability to process nutrients
  • You are pregnant or planning to become pregnant during the study period
  • You are currently enrolled in any treatment programme that involves being guided to increase your food intake (refeeding)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elizabeth Osuch, London Health Sciences Centre

Phone: 519-646-6000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility of Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov